目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Market characteristics
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product
Market segments
Comparison by Product
SGDs - Market size and forecast 2020-2025
TGDs - Market size and forecast 2020-2025
FGDs - Market size and forecast 2020-2025
Market opportunity by Product

Customer landscape
Overview

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
AbbVie Inc.
BIOCODEX SAS
Cadila Healthcare Ltd.
Epygenix Therapeutics Inc.
H. Lundbeck AS
PTC Therapeutics Inc.
Supernus Pharmaceuticals Inc.
Takeda Pharmaceutical Co. Ltd.
Zogenix Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Product - Market share 2020-2025 (%)
22: Comparison by Product
23: SGDs - Market size and forecast 2020-2025 ($ million)
24: SGDs - Year-over-year growth 2020-2025 (%)
25: TGDs - Market size and forecast 2020-2025 ($ million)
26: TGDs - Year-over-year growth 2020-2025 (%)
27: FDGs - Market size and forecast 2020-2025 ($ million)
28: FDGs - Year-over-year growth 2020-2025 (%)
29: Market opportunity by Product
30: Customer landscape
31: Market share By Geographical Landscape 2020-2025 (%)
32: Geographic comparison
33: North America - Market size and forecast 2020-2025 ($ million)
34: North America - Year-over-year growth 2020-2025 (%)
35: Europe - Market size and forecast 2020-2025 ($ million)
36: Europe - Year-over-year growth 2020-2025 (%)
37: Asia - Market size and forecast 2020-2025 ($ million)
38: Asia - Year-over-year growth 2020-2025 (%)
39: ROW - Market size and forecast 2020-2025 ($ million)
40: ROW - Year-over-year growth 2020-2025 (%)
41: Key leading countries
42: Market opportunity By Geographical Landscape ($ million)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: AbbVie Inc. - Overview
50: AbbVie Inc. - Product and service
51: AbbVie Inc. - Key offerings
52: AbbVie Inc. - Key customers
53: AbbVie Inc. - Segment focus
54: BIOCODEX SAS - Overview
55: BIOCODEX SAS - Product and service
56: BIOCODEX SAS - Key offerings
57: BIOCODEX SAS - Key customers
58: BIOCODEX SAS - Segment focus
59: Cadila Healthcare Ltd. - Overview
60: Cadila Healthcare Ltd. - Product and service
61: Cadila Healthcare Ltd. - Key offerings
62: Cadila Healthcare Ltd. - Key customers
63: Cadila Healthcare Ltd. - Segment focus
64: Epygenix Therapeutics Inc. - Overview
65: Epygenix Therapeutics Inc. - Product and service
66: Epygenix Therapeutics Inc. - Key offerings
67: Epygenix Therapeutics Inc. - Key customers
68: Epygenix Therapeutics Inc. - Segment focus
69: H. Lundbeck AS - Overview
70: H. Lundbeck AS - Business segments
71: H. Lundbeck AS - Key offerings
72: H. Lundbeck AS - Key customers
73: H. Lundbeck AS - Segment focus
74: PTC Therapeutics Inc. - Overview
75: PTC Therapeutics Inc. - Business segments
76: PTC Therapeutics Inc. - Key offerings
77: PTC Therapeutics Inc. - Key customers
78: PTC Therapeutics Inc. - Segment focus
79: Supernus Pharmaceuticals Inc. - Overview
80: Supernus Pharmaceuticals Inc. - Business segments
81: Supernus Pharmaceuticals Inc. - Key offerings
82: Supernus Pharmaceuticals Inc. - Key customers
83: Supernus Pharmaceuticals Inc. - Segment focus
84: Takeda Pharmaceutical Co. Ltd. - Overview
85: Takeda Pharmaceutical Co. Ltd. - Product and service
86: Takeda Pharmaceutical Co. Ltd. - Key offerings
87: Takeda Pharmaceutical Co. Ltd. - Key customers
88: Takeda Pharmaceutical Co. Ltd. - Segment focus
89: Zogenix Inc. - Overview
90: Zogenix Inc. - Product and service
91: Zogenix Inc. - Key offerings
92: Zogenix Inc. - Key customers
93: Zogenix Inc. - Segment focus
94: Currency conversion rates for US$
95: Research Methodology
96: Validation techniques employed for market sizing
97: Information sources
98: List of abbreviations